{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T08:58:06Z","timestamp":1762160286196},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1986,10,1]],"date-time":"1986-10-01T00:00:00Z","timestamp":528508800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch. Pharmacol."],"published-print":{"date-parts":[[1986,10]]},"DOI":"10.1007\/bf00505811","type":"journal-article","created":{"date-parts":[[2004,11,16]],"date-time":"2004-11-16T12:00:50Z","timestamp":1100606450000},"page":"125-132","source":"Crossref","is-referenced-by-count":26,"title":["3-Methoxytyramine accumulation: Effects of typical neuroleptics and various atypical compounds"],"prefix":"10.1007","volume":"334","author":[{"given":"Charles F.","family":"Saller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andre I.","family":"Salama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/j.2042-7158.1980.tb13066.x","volume":"32","author":"T Alander","year":"1980","unstructured":"Alander T, Grabowska-Anden M, Anden NE (1980) Physiological significance of dopamine autoreceptors as studied following their selective blockade by molindone. J Pharm Pharmacol 32:780?782","journal-title":"J Pharm Pharmacol"},{"key":"CR2","first-page":"276","volume":"44","author":"J Ananth","year":"1983","unstructured":"Ananth J, Carrillo R (1983) Tardive dyskinesia with molindone. J Clin Psychiatr 44:276","journal-title":"J Clin Psychiatr"},{"key":"CR3","first-page":"447","volume":"35","author":"FJ Ayd Jr","year":"1974","unstructured":"Ayd FJ Jr (1974) A critical evaluation of molindone (Moban): A new indole derivative neuroleptic. Dis Nerv Syst 35:447?452","journal-title":"Dis Nerv Syst"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1600-0773.1973.tb01543.x","volume":"33","author":"OJ Broch Jr","year":"1973","unstructured":"Broch OJ Jr (1973) The in vivo effect of tropolone on noradrenaline metabolism and catechol-O-methyltransferase activity in tissues of the rat. Acta Pharmacol Toxicol 33:417?428","journal-title":"Acta Pharmacol Toxicol"},{"key":"CR5","series-title":"Wenner-Gren Center International Symposium Series","first-page":"305","volume-title":"Antipsychotic drugs, pharmacodynamics and pharmacokinetics","author":"BS Bunney","year":"1975","unstructured":"Bunney BS, Aghajanian GK (1975) The effect of antipsychotic drugs on the firing of dopaminergic neurons. In: Seduall G, Uvnas G, Zatterman Y (eds), Antipsychotic drugs, pharmacodynamics and pharmacokinetics, Wenner-Gren Center International Symposium Series, vol 25. Pergamon Press, New York, pp 305?317"},{"key":"CR6","first-page":"560","volume":"185","author":"BS Bunney","year":"1973","unstructured":"Bunney BS, Walter JR, Roth RH, Aghajanian GK (1973) Dopaminergic neurons: Effect of antipsychotic drugs and amphetamine on single cell activity. J Pharmacol Exp Ther 185:560?571","journal-title":"J Pharmacol Exp Ther"},{"key":"CR7","first-page":"349","volume":"1","author":"BS Bunney","year":"1975","unstructured":"Bunney BS, Roth RH, Aghajanian GK (1975) Effects of molindone on central dopaminergic neuronal activity and metabolism: Similarity to other neuroleptics. Psychopharmacol Comm 1:349?358","journal-title":"Psychopharmacol Comm"},{"key":"CR8","first-page":"759","volume":"38","author":"EW Camp III","year":"1977","unstructured":"Camp EW, III (1977) Tardive dyskinesia: Oral facial dyskinesia with Moban. Dis Nerv Syst 38:759","journal-title":"Dis Nerv Syst"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1748-1716.1962.tb02422.x","volume":"55","author":"A Carlsson","year":"1962","unstructured":"Carlsson A, Hillarp NA (1962) Formation of phenolic acid in brain after administration of 3,4-dihyroxyphenylalanine. Acta Physiol Scand 55:95?100","journal-title":"Acta Physiol Scand"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF00504705","volume":"284","author":"A Carlsson","year":"1974","unstructured":"Carlsson A, Lindquist M, Kehr W (1974) Postmortal accumulation of 3-methoxytyramine in brain. Naunyn-Schmiedberg's Arch Pharmacol 284:365?372","journal-title":"Naunyn-Schmiedberg's Arch Pharmacol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/BF00427460","volume":"84","author":"G Chouinard","year":"1984","unstructured":"Chouinard G, Annable L (1984) An early Phase II clinical trial of BW 234U in the treatment of acute schizophrenia in newly admitted patients. Psycho pharmacology 84:282?284","journal-title":"Psycho pharmacology"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/0006-2952(83)90627-5","volume":"32","author":"M Cimino","year":"1983","unstructured":"Cimino M, Ponzio F, Achilli G, Vantini G, Perego C, Algeri S, Garattini S (1983) Dopaminergic effects of buspirone, a novel anxiolytic agent. Biochem Pharmacol 32:1069?1074","journal-title":"Biochem Pharmacol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0028-3908(83)90148-X","volume":"22","author":"P Conway","year":"1983","unstructured":"Conway P, Uretsky NJ (1983) Enhanced stereotyped response to amphetamine after pretreatment with small doses of molindone. Neuropharmacology 22:579?586","journal-title":"Neuropharmacology"},{"key":"CR14","first-page":"89","volume-title":"Long-term effects of neuroleptics","author":"I Creese","year":"1980","unstructured":"Creese I, Snyder SH (1980) Chronic neuroleptic treatment and dopamine receptor regulation. In: Cattabeni F, Racagni G, Spano PF, Costa E (eds) Long-term effects of neuroleptics. Raven Press, New York, pp 89?94"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/ddr.430060103","volume":"6","author":"J Davidson","year":"1985","unstructured":"Davidson J, Dren A, Miller R, Manberg P, Kilts C, Wingfield M (1985) BW 234: A nondopamine receptor-blocking antipsychotic without extrapyramidal side effects. Drug Dev Res 6:13?17","journal-title":"Drug Dev Res"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0014-2999(78)90207-8","volume":"52","author":"AM DiGiulio","year":"1978","unstructured":"DiGiulio AM, Groppetti A, Cattabeni F, Galli CL, Maggi A, Algeri S, Ponzio F (1978) Significance of dopamine metabolites in the evaluation of drugs acting on dopaminergic neurons. Eur J Pharmacol 52:201?207","journal-title":"Eur J Pharmacol"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/0006-8993(77)90084-1","volume":"136","author":"JZ Fields","year":"1977","unstructured":"Fields JZ, Reisine TD, Yamamura HI (1977) Biochemical demonstration of dopaminergic receptors in rat and human brain using [3H]spiroperidol. Brain Res 136:578?584","journal-title":"Brain Res"},{"key":"CR18","first-page":"267","volume":"10","author":"R Ferris","year":"1984","unstructured":"Ferris R, McKenzie G, Howard J, Soroko F, Harfenist M, Maxwell R (1984) The pharmacology of a new antipsychotic agent free of direct dopamine blocking activity. Neurosci Abs 10:267","journal-title":"Neurosci Abs"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1471-4159.1976.tb10410.x","volume":"27","author":"GL Galli","year":"1976","unstructured":"Galli GL, Cattabeni F, Eros T, Spano PF (1976) A mass fragmentographic assay of 3-methoxytyramine in rat brain. J Neurochem 27:795?798","journal-title":"J Neurochem"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF00421473","volume":"40","author":"J Gerlach","year":"1975","unstructured":"Gerlach J, Thorsen K, Fog R (1975) Extrapyramidal reactions and amine metabolites in cerebrospinal fluid during haloperidol and clozapine treatment of schizophrenia patients. Psychopharmacologia 40:341?350","journal-title":"Psychopharmacologia"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1176\/ajp.136.9.1184","volume":"136","author":"HL Goldberg","year":"1979","unstructured":"Goldberg HL, Finnerty RJ (1979) The comparative efficacy of buspirone and diazepam in the treatment of anxiety. Am J Psychiatr 136:1184?1187","journal-title":"Am J Psychiatr"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1111\/j.1471-4159.1985.tb07189.x","volume":"44","author":"D Grigoriadis","year":"1985","unstructured":"Grigoriadis D, Seeman P (1985) Complete conversion of brain D-2 dopamine receptors from high- to the low-affinity state for dopamine agonists, using sodium ions and guanine nucleotide. J Neurochem 44:1925?1935","journal-title":"J Neurochem"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/0024-3205(78)90105-4","volume":"23","author":"A Groppetti","year":"1978","unstructured":"Groppetti A, Parenti M, Galli CL, Bugatti A, Cattabeni F, Di Giulio AM, Racagni G (1978) 3-Methoxytyramine and different neuroleptics: Dissociation from HVA and DOPAC. Life Sci 23:1763?1768","journal-title":"Life Sci"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0014-2999(83)90381-3","volume":"91","author":"J Hyttel","year":"1983","unstructured":"Hyttel J (1983) SCH 23390 ? The first selective D-1 antagonist. Eur J Pharmacol 91:153?154","journal-title":"Eur J Pharmacol"},{"key":"CR25","first-page":"462","volume":"226","author":"LC Iorio","year":"1983","unstructured":"Iorio LC, Barnet A, Leitz FH, Houser VP, Korduba CA (1983) SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems. J Pharmacol Exp Ther 226:462?468","journal-title":"J Pharmacol Exp Ther"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1748-1716.1968.tb04093.x","volume":"73","author":"J Jonason","year":"1968","unstructured":"Jonason J, Rutledge CO (1968) The effect of protriptyline on the metabolism of dopamine and noradrenaline in rabbit brain in vitro. Acta Physiol Scand 73:161?175","journal-title":"Acta Physiol Scand"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF00507343","volume":"293","author":"W Kehr","year":"1976","unstructured":"Kehr W (1976) 3-Methoxytyramine as an indicator of impulseinduced dopamine release in rat brain in vivo. Naunyn-Schmiedeberg's Arch Pharmacol 293:209?215","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"CR28","first-page":"405","volume-title":"Aninmal models in psychiatry and neurology","author":"RM Kobayashi","year":"1978","unstructured":"Kobayashi, RM, Fields JZ, Hruska RE, Beaumont K, Yamamura HI (1978) Brain neurotransmitter receptors and chronic antipsychotic drug treatment: A model for tardive dyskinesia. In: Hanin I, Usdin E (eds) Aninmal models in psychiatry and neurology. Pergamon Press, New York, pp 405?409"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1073\/pnas.79.13.4212","volume":"79","author":"MH Makman","year":"1982","unstructured":"Makman MH, Dvorkin B, Klein PN (1982) Sodium ion modulates D2 receptor characteristics of dopamine agonist and antagonist binding sites in striatum and retina. Proc Natl Acad Sci USA 79:4212?4216","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/BF00506189","volume":"325","author":"MP Martres","year":"1984","unstructured":"Martres MP, Sokoloff P, Delandre M, Schwartz J-C, Protais P, Constentin J (1984) Selection of dopamine antagonists discriminating various behavioral responses and radioligand binding sites. Naunyn-Schmiedeberg's Arch Pharmacol 325:102?115","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1523\/JNEUROSCI.03-04-00733.1983","volume":"3","author":"BA McMillen","year":"1983","unstructured":"McMillen BA, Matthews RT, Sanghera MK, Shepard PD, German DC (1983) Dopamine receptor antagonism by the novel antianxiety drug buspirone. J Neurosci 3:733?738","journal-title":"J Neurosci"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/BF00432549","volume":"76","author":"E Meller","year":"1982","unstructured":"Meller E (1982) Chronic molindone treatment: Relative inability to elicit dopamine receptor supersensitivity in rats. Psychopharmacology 76:222?227","journal-title":"Psychopharmacology"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/0024-3205(85)90159-6","volume":"36","author":"E Meller","year":"1985","unstructured":"Meller E, Kuga S, Friedhoff AJ, Goldstein M (1985) Selective D2 receptor agonists prevent catalepsy induced by SCH 23390, a selective D1 antagonist. Life Sci 36:1857?1864","journal-title":"Life Sci"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(85)90769-3","volume":"340","author":"P Onali","year":"1985","unstructured":"Onali P, Mereu G, Olianas MC, Bunse B, Rossetti Z, Gessa GL (1985) SCH 23390, a selective D1 dopamine receptor blocker, enhances the firing rate of nigral dopaminergic neurons but fails to activate striatal tyrosine hydroxylase. Brain Res 340:1?7","journal-title":"Brain Res"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0304-3940(81)90206-8","volume":"27","author":"F Ponzio","year":"1981","unstructured":"Ponzio F, Achilli G, Perego C, Algeri S (1981) Differential effects of certain dopaminergic drugs on the striatal concentrations of dopamine metabolites, with special reference to 3-methoxytyramine. Neurosci Lett 27:61?67","journal-title":"Neurosci Lett"},{"key":"CR36","first-page":"1279","volume":"20","author":"AJ Peuch","year":"1981","unstructured":"Peuch AJ, Rioux P, Poncelet M, Brchet D, Chermat R, Simon P (1981) Pharmacological properties of new antipsychotic agents: Use of animal models. Neuropharmacology 20:1279?1284","journal-title":"Neuropharmacology"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0091-3057(84)90137-0","volume":"21","author":"A Robertson","year":"1984","unstructured":"Robertson A, MacDonald C (1984) Atypical neuroleptics clozapine and thioridazine enhance amphetamine-induced stereotypy. Pharmacol Biochem Behav 21:97?101","journal-title":"Pharmacol Biochem Behav"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/B978-0-08-017922-3.50103-9","volume-title":"Frontiers in catecholamine research","author":"RH Roth","year":"1973","unstructured":"Roth RH, Walter JR, Aghajanian GK (1973) Effect of impulse flow on the release and synthesis of dopamine in the rat striatum. In: Usdin E, Snyder SH (ed) Frontiers in catecholamine research. Pergamon Press, New York, pp 567?574"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0378-4347(84)80036-5","volume":"309","author":"CF Saller","year":"1984","unstructured":"Saller CF, Salama AI (1984) Rapid automated analysis of biogenic amines and their metabolites using reverse-phase high performance liquid chromatography with electrochemical detection. J Chromatog 309:287?298","journal-title":"J Chromatog"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/0024-3205(85)90443-6","volume":"36","author":"DW Schulz","year":"1985","unstructured":"Schulz DW, Stapler L, Mailman RB (1985) SCH 23390 causes persistent antidopaminergic effects in vivo: Evidence for longterm occupation of receptors. Life Sci 36:1941?1948","journal-title":"Life Sci"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/ddr.430050412","volume":"5","author":"G Schwarcz","year":"1985","unstructured":"Schwarcz G, Halaris A, Dren A, Manberg P (1985) Open label evaluation of the novel antipsychotic compound BW 234U in chronic schiziophrenics. Drug Dev Res 5:387?393","journal-title":"Drug Dev Res"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF00432038","volume":"84","author":"JA Severson","year":"1984","unstructured":"Severson JA, Robinson HE, Simpson GM (1984) Neuroleptic-induced striatal dopamine receptor supersensitivity in mice: Relationship to dose and drug. Psychopharmacology 84:115?119","journal-title":"Psychopharmacology"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/archpsyc.1979.01780060047005","volume":"36","author":"B Shopsin","year":"1979","unstructured":"Shopsin B, Klein H, Aaronsom M, Collora M (1979) Clozapine, chlorpromazine, and placebo in newly hospitalized, acutely schizophrenic patients: A controlled double-blind comparison. Arch Gen Psychiatr 36:657?664","journal-title":"Arch Gen Psychiatr"},{"key":"CR44","first-page":"679","volume":"16","author":"GM Simpson","year":"1974","unstructured":"Simpson GM, Varga E (1974) Clozapine, a new antipsychotic agent. Curr Ther Res 16:679?686","journal-title":"Curr Ther Res"},{"key":"CR45","first-page":"316","volume-title":"The neurobiology of the nucleus accumbens","author":"HC Stanton","year":"1981","unstructured":"Stanton HC, Taylor DP, Riblet LA (1981) Buspirone ? An anxioselective drug with dopaminergic action. In: Chronister RB, DeFrance JF (eds). The neurobiology of the nucleus accumbens. Haer Institute, Brunswick, ME, pp 316?319"},{"key":"CR46","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/294366a0","volume":"294","author":"JC Stoof","year":"1981","unstructured":"Stoof JC, Kebabian JW (1981) Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum. Nature 294:366?368","journal-title":"Nature"},{"key":"CR47","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/cpt196782261","volume":"8","author":"AA Sugerman","year":"1976","unstructured":"Sugerman AA, Herman JJ (1976) Molindone: An indole derivative with antipsychotic activity. Clin Pharmacol Ther 8:261?265","journal-title":"Clin Pharmacol Ther"},{"key":"CR48","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF00499838","volume":"315","author":"PC Waldmeier","year":"1981","unstructured":"Waldmeier PC, Lauber J, Blum W, Richter WJ (1981) 3-Methoxytyramine: Its suitability as an indicator of synaptic dopamine release. Naunyn-Schmiedeberg's Arch Pharmacol 315:219?225","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"CR49","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF00498834","volume":"296","author":"JR Walters","year":"1976","unstructured":"Walters JR, Roth RH (1976) Dopaminergic neurons: An in vivo system for measuring drug interactions with presynaptic receptors. Naunyn-Schmiedeberg's Arch Pharmacol 296:5?14","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"CR50","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/j.1471-4159.1982.tb08685.x","volume":"38","author":"BHC Westerink","year":"1982","unstructured":"Westerink BHC, Spaan SJ (1982) On the significance of endogenous 3-methoxytyramine for the effects of centrally acting drugs on dopamine release in the rat brain. J Neurochem 38:680?686","journal-title":"J Neurochem"},{"key":"CR51","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0024-3205(83)90386-7","volume":"33","author":"PL Wood","year":"1983","unstructured":"Wood PL, Nair NPV, Lal S, Etienne P (1983) Buspirone: A potential atypical neuroleptic. Life Sci 33:269?273","journal-title":"Life Sci"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00505811.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00505811\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00505811","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T11:36:17Z","timestamp":1705318577000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00505811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986,10]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1986,10]]}},"alternative-id":["BF00505811"],"URL":"https:\/\/doi.org\/10.1007\/bf00505811","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[1986,10]]}}}